NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE:MRK) between February 3, 2022 and ...

The extension comes hours after the Cleveland Browns agreed to a new four-year deal with superstar defensive end Myles Garrett. Garrett’s deal is worth $40 million a year, including $123.5 ...

The Denver Nuggets and Oklahoma City Thunder are poised for a highly-anticipated Western Conference clash on Sunday afternoon, pitting the top-two MVP candidates against each other in the final ...

FRANKFURT (Reuters) - Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug ...

With the NBA regular season now in its home stretch, the race for the MVP award has heated up and may be one of the closest races in recent memory. This season has been a great one thus far for ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

HYDERABAD, India (Reuters) - Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company ...

Ivonescimab, the new drug, was found in a trial conducted in China to have bested Keytruda, the blockbuster medication developed by Merck that has raked in more than $130 billion in sales for the ...

Diana Taurasi, the WNBA's all-time leading scorer, a three-time champion, two-time Finals MVP and 2009 MVP, announced her retirement Tuesday in an interview with Time Magazine. Taurasi ...